[Studies on pathogen spectra and resistance quotas of infection producing organisms in surgical and urologic diseases in common hospitalization and separate ambulatory settings].
D000553:Ambulatory Care; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects / Q000472:pathogenicity*; D002701:Chloramphenicol / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects; D006760:Hospitalization; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009545:Nifuratel / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D013210:Staphylococcus / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013530:Surgical Wound Infection / Q000188:drug therapy; D013752:Tetracycline / Q000494:pharmacology; D014552:Urinary Tract Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D013449:Sulfonamides; D009268:Nalidixic Acid; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D013752:Tetracycline; D009355:Neomycin; D010400:Penicillin G; D009545:Nifuratel; D013307:Streptomycin
Untersuchunger über Keimspektren und Resistenzquoten von Infektionserregern chirurgischer und urologischer Erkrankungen in gemeinsamen stationären und getrennten ambulanten Bereichen